Wedbush Securities’s Boston Scientific BSX Stock Holding History

Wedbush Securities’s Portfolio BSX Stock Details BSX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$453K	Buy	10,620 +1,530	+17%	+$83.1K	0.01%	756
2026 Q1	$570K	Buy	9,090 +1,923	+27%	+$154K	0.02%	640
2025 Q4	$683K	Buy	7,167 +3,907	+120%	+$383K	0.02%	573
2025 Q3	$318K	Buy	3,260 +232	+8%	+$24K	0.01%	822
2025 Q2	$325K	Buy	3,028 +30	+1%	+$3.04K	0.01%	804
2025 Q1	$302K	Buy	2,998 +162	+6%	+$16.3K	0.01%	814
2024 Q4	$253K	Sell	2,836 -18	-0.6%	-$1.58K	0.01%	906
2024 Q3	$239K	Sell	2,854 -401	-12%	-$31.6K	0.01%	914
2024 Q2	$251K	Buy	+3,255	New	+$238K	0.01%	956

Other funds holding BSX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

California State Teachers Retirement System (CalSTRS) West Sacramento, California $782B AUM 28.39% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

Wedbush Securities's BSX Position: Q2 2026 in Review

Wedbush Securities increased its Boston Scientific (BSX) stake by 17% in Q2 2026, buying an estimated $83.1K and bringing the position to 10,620 shares worth $453K. The position accounts for 0.01% of the portfolio, ranked #756.

Wedbush Securities first reported a position in BSX in Q2 2024 and has held it in 9 quarters since. The position peaked at $683K in Q4 2025. 1,470 funds tracked by Wall St. Rank hold BSX as of Q2 2026.

Wedbush Securities held 10,620 shares of Boston Scientific worth $453K as of Q2 2026.
Wedbush Securities bought 1,530 Boston Scientific shares in Q2 2026, an estimated $83.1K.
Boston Scientific made up 0.01% of Wedbush Securities's portfolio in Q2 2026, its #756 holding.
Wedbush Securities first reported a position in Boston Scientific in Q2 2024 and has held it in 9 quarters since.
Wedbush Securities's Boston Scientific position peaked at $683K in Q4 2025.
1,470 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.

Based on Wedbush Securities's 13F filing for Q2 2026, filed 28 Jul 2026.